Contenu disponible en anglais seulement.
Bulletin de la Bourse
MCI Onehealth Technologies Inc. (DRDR) inscrit à la Bourse de Toronto
4 janvier 2021
| Issuer: | MCI Onehealth Technologies Inc. (the "Company") |
| Security: | Class A Subordinate Voting Shares ("Subordinate Voting Shares") |
| Symbol(s): | DRDR |
| Issue price per security: | $5.00 |
| Number of securities issued and outstanding: | 46,000,000 |
| Number of securities reserved for issuance: | 5,500,000 |
| Listing category: | Industrial, Non Exempt |
| Trading currency: | CDN$ |
| Transaction: | Initial public offering (the "Offering"). |
| Listing date: | January 5, 2021 (as at 5:01 pm) in anticipation of closing of the Offering. |
| Anticipated closing date: | January 6, 2021 (prior to the opening) |
| Posted for trading date: | January 6, 2021 (at the opening) subject to confirmation of closing of the Offering. |
| Other market(s): | None |
| Temporary market maker: | Independent Trading Group (ITG) Inc. |
| Security ownership registration: | Non-certificated inventory |
| Investor relations: | Alex Dobranowski Chief Executive Officer 905-966-5289 Email: alex@mcionehealth.com -and- Scott Nirenberski Chief Financial Officer 905-960-6717 Email: scott@mcionehealth.com |
| Incorporation: | Canada Business Corporations Act |
| Fiscal year end: | December 31 |
| Nature of business: | The principal activities of the Company are the operation of primary care medical clinics in the provinces of Alberta and Ontario. |
| Transfer agent and registrar: | Computershare Investor Services Inc. at its principal office in Toronto. |
| Dividends: | The Company does not anticipate paying cash dividends on the Subordinate Voting Shares in the foreseeable future. |
| Sponsorship: | Waived |
| Disclosure document: | Prospectus dated December 29, 2020 which is available at . |
| Initial public offering: | 6,000,000 Subordinate Voting Shares are being offered to the public from treasury at a price of $5.00 per share (the "Offering Price"). In addition, the underwriters have been granted an over-allotment option to purchase up to an additional 900,000 Subordinate Voting Shares from treasury at the Offering Price. |
| TSX contact: | Chris Birkett, Managing Director, ÍÃ×ÓÏÈÉú. |